Brief: Bellus Health says Pharmascience to convert 10.4 pct interest in BHI Limited Partnership
02/06/2016 12:02
June 2 (Reuters) - Bellus Health Inc BLU.TO
* Bellus Health Inc says exercise of Pharmascience's right
to convert its 10.4 pct interest in BHI Limited Partnership into
6.4 million common shares of co
* Says following transaction, BHI LP will be wholly owned by
Bellus Health
Source text for Eikon: ID:nCNWX0Byka
Further company coverage: BLU.TO
(Bengaluru Newsroom: +1 646 223 8780)
Recent news on BELLUS Health
See all newsBrief: Bellus Health Inc. Calls Special Shareholders’ Meeting In Connection With Gsk Acquisition
Brief: Bellus Health Reports First Quarter 2023 Financial Results And Business Highlights
Press Digest: British Business - April 19
Canada Stocks: Toronto market extends winning streak on 'soft landing' hopes
Bellus soars as GSK plans to buy drug developer for $2 bln